Florida Licenses Provista Dx for Clinical Lab Services | GenomeWeb

NEW YORK (GenomeWeb News) – Florida has licensed Provista Diagnostics to offer clinical laboratory services for patient samples originating within the state, the company said today.

The Scottsdale, Ariz.-based molecular diagnostic firm received the Out of State Laboratory License from the Clinical Laboratory Unit of the Florida Agency for Healthcare Administration. As a result, Provista can now offer its clinical lab services to 49 of the 50 states in the US, with New York being the exception.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.